Advertisement
Advertisement
August 12, 2014
Bolton Medical Conducts Postapproval Study of the Relay Thoracic Stent Graft
August 13, 2014—Bolton Medical, Inc. is conducting the postapproval study of the Relay thoracic stent graft with Plus delivery system for thoracic endovascular aneurysm repair (TEVAR). The company announced US Food and Drug Administration approval of the device in September 2012.
According to the company, the Relay stent graft is specifically designed for treatment of the thoracic aorta. It is offered in a wide range of sizes to accommodate many different anatomies of patients with thoracic aortic aneurysms and penetrating atherosclerotic ulcers. The new Relay thoracic stent graft is paired with the company’s four-step Plus delivery system that allows for easy navigation and precise placement in a variety of anatomies.
Krishna Mannava, MD, successfully performed the first procedure in the study in April. Dr. Mannava is Director of Vascular Services at Fairfield Medical Center in Lancaster, Ohio. In the company’s announcement, Dr. Mannava commented, “We had a great outcome in a high-risk patient with difficult anatomy. I feel the design of the coaxial delivery system and the Bolton Medical Relay stent graft itself facilitate precise placement and conformability in both conventional and complex TEVAR procedures.”
Advertisement
Advertisement
